Eli Lilly says its weight loss drug Zepbound outperformed Wegovy in a study The result may allow the company to make marketing claims about its drug’s efficacy vs. Novo Nordisk’s

https://www.statnews.com/2024/12/04/zepbound-beats-wegovy-obesity-drug-clinical-trial-eli-lilly-novo-nordisk/?utm_campaign=daily_recap&utm_medium=email&_hsenc=p2ANqtz-_ThQ52HiGHu_QJpga8DiWNAlqen3JNFaRoNW6oXUqCzKz9AG2ud4tLGxq8GIcudygHe47yIPxqIImv5ZFJWbfqz8bd9Q&_hsmi=337057040&utm_content=337057040&utm_source=hs_email